- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03100812
Asian American Partnerships in Research and Empowerment (AsPIRE) (AsPIRE)
The proposed intervention is part of a multi-year year grant awarded to the NYU Center for the Study of Asian American Health by to the National Institutes of Health/National Center for Minority Health and Health Disparities (NIH/NCMHD). The funding mechanism is specifically the NCMHD Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities: Intervention Research Phase (R24).
The objective of this study is to implement and assess the efficacy of a Community Health worker (CHW) intervention to improve hypertension management and access to care among Filipino Americans living in New York and New Jersey. It is believed that when compared to individuals receiving the less intensive CHW intervention, Filipino Americans receiving the more intensive CHW intervention will:
H1: Exhibit greater compliance with appointment keeping. H2: Exhibit greater compliance with medication taking H3: Show greater reductions in mean systolic and mean diastolic blood pressure. H4: Be more likely to exhibit controlled blood pressure
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
New York
-
New York, New York, Estados Unidos, 10016
- New York University School of Medicine
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
The population of interest is Filipino American men and women residing in New York City. An individual is eligible for the CHW intervention if he/she is
- of Filipino descent,
- an English or Tagalog-speaker
- a resident of New York City.
- identified as hypertensive based on
- The average of the 2nd and 3rd readings from both arms (right arm) with at least 1 high systolic BP (>140mmHg) or 1 high diastolic BP reading (>90mmHg) for nondiabetics, or 1 high systolic BP (>130mmHg) or 1 high diastolic BP reading (>80mmHg) for diabetics at point of screening for this study.
- Or if participant reports to be taking antihypertensive medication. Therefore this study will include individuals with untreated hypertension (not taking antihypertensive medication), uncontrolled hypertension (i.e. elevated blood pressure despite taking antihypertensive medication), and controlled hypertension (i.e. taking antihypertensive medication but BP is under control). Individuals presenting with untreated high blood pressure will be referred to a physician to confirm diagnosis of hypertension.
An individual is ineligible for enrollment in the CHW intervention if he/she
- is on renal dialysis since their treatment is beyond the scope of this CHW intervention
- has an acute or terminal illness or serious mental illness that deems an individual ineligible for study participation
- is participating in another hypertension or CVD study
- has had a history of a heart attack, stroke, or congestive heart failure, since their treatment is beyond the scope of this CHW intervention
- has a blood pressure average below 140/90 for non-diabetics and not taking antihypertensive medication, and an average of 130/80 for diabetics not taking antihypertensive medication.
- is below 25 or over 75 years of age
- lives outside of NYC
Exclusion Criteria:
An individual is ineligible for enrollment in the CHW intervention if he/she
- is on renal dialysis since their treatment is beyond the scope of this CHW intervention
- has an acute or terminal illness or serious mental illness that deems an individual ineligible for study participation
- is participating in another hypertension or CVD study
- has had a history of a heart attack, stroke, or congestive heart failure, since their treatment is beyond the scope of this CHW intervention
- has a blood pressure average below 140/90 for non-diabetics and not taking antihypertensive medication, and an average of 130/80 for diabetics not taking antihypertensive medication.
- is below 25 or over 75 years of age
- lives outside of NYC
An individual is ineligible for enrollment in the CHW intervention if he/she
- is on renal dialysis since their treatment is beyond the scope of this CHW intervention
- has an acute or terminal illness or serious mental illness that deems an individual ineligible for study participation
- is participating in another hypertension or CVD study
- has had a history of a heart attack, stroke, or congestive heart failure, since their treatment is beyond the scope of this CHW intervention
- has a blood pressure average below 140/90 for non-diabetics and not taking antihypertensive medication, and an average of 130/80 for diabetics not taking antihypertensive medication.
- is below 25 or over 75 years of age
- lives outside of NYC
An individual is ineligible for enrollment in the CHW intervention if he/she
- is on renal dialysis since their treatment is beyond the scope of this CHW intervention
- has an acute or terminal illness or serious mental illness that deems an individual ineligible for study participation
- is participating in another hypertension or CVD study
- has had a history of a heart attack, stroke, or congestive heart failure, since their treatment is beyond the scope of this CHW intervention
- has a blood pressure average below 140/90 for non-diabetics and not taking antihypertensive medication, and an average of 130/80 for diabetics not taking antihypertensive medication.
- is below 25 or over 75 years of age
- lives outside of NYC
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Grupo A
|
Group A participants will attend 4 monthly 90 minute group health education sessions that provide the tools and strategies to promote heart health to Filipino American individuals, families, and communities on high blood pressure and CVD.
The CHWs will lead these sessions utilizing NHLBI's Healthy Heart Healthy Family, A CHW's Manual for the Filipino Community.
Each of the group health education sessions will discuss different content related to CVD, hypertension, and other CVD risk factors.
The first session focuses on assessing heart disease risk and recognition of heart attack signs.
The second session focuses on physical activity and weight management and blood pressure control.
The third session addresses control of cholesterol, and diabetes.
The final 4th session teaches participants about nutrition and living smoke free.
|
|
Experimental: Grupo B
|
Individuals randomized to the less intensive CHW intervention will have the baseline, 4 month, and 8 month interviews and blood pressure measurements will be collected in those succeeding time points.
Participants will also receive a 30 minute one on one session from the CHW and a referral to a physician if needed.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Medication Adherance measured using the Hill-Bone Compliance to High Blood Pressure Therapy Scale
Periodo de tiempo: 12 Months
|
This scale is comprised of 14 items in three subscales; one subscale pertains to adherence to medication taking.
Three blood pressure readings will be taken; the second and third will be averaged.
|
12 Months
|
|
Measures of Intensity and Fidelity of Community Health Worker Intervention
Periodo de tiempo: 12 Months
|
Attendance at group sessions and individual home visits will be recorded to determine intervention dosage.
|
12 Months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Chau Trinh, MD, NYU Langone Health
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 07-1131
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre More intensive CHW Intervention
-
Stockholm UniversityYale University; University of Chile; EDI Global; Elizabeth Glaser Pediatric AIDS... y otros colaboradoresTerminadoCrianza de los hijos | Desarrollo Infantil TempranoTanzania